当前位置: X-MOL 学术Arthritis Res. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The integrin CD11b inhibits MSU-induced NLRP3 inflammasome activation in macrophages and protects mice against MSU-induced joint inflammation
Arthritis Research & Therapy ( IF 4.4 ) Pub Date : 2024-06-11 , DOI: 10.1186/s13075-024-03350-5
Driss Ehirchiou , Ilaria Bernabei , Vishnuprabu Durairaj Pandian , Sonia Nasi , Veronique Chobaz , Mariela Castelblanco , Alexander So , Fabio Martinon , Xiaoyun Li , Hans Acha-Orbea , Thomas Hugle , Li Zhang , Nathalie Busso

In gout, monosodium urate crystals are taken up by macrophages, triggering the activation of the NLRP3 inflammasome and the maturation of IL-1β. This study aimed to investigate the role of integrin CD11b in inflammasome activation in macrophages stimulated by MSU. BMDM from WT and CD11b KO mice were stimulated in vitro with MSU crystals. Cellular supernatants were collected to assess the expression of the inflammatory cytokines by enzyme-linked immunosorbent assay and western blot methods. The role of integrin CD11b in MSU-induced gouty arthritis in vivo was investigated by intra-articular injection of MSU crystals. Real-time extracellular acidification rate and oxygen consumption rate of BMDMs were measured by Seahorse Extracellular Flux Analyzer. We demonstrate that CD11b-deficient mice developed exacerbated gouty arthritis with increased recruitment of leukocytes in the joint and higher IL-1β levels in the sera. In macrophages, genetic deletion of CD11b induced a shift of macrophage metabolism from oxidative phosphorylation to glycolysis, thus decreasing the overall generation of intracellular ATP. Upon MSU stimulation, CD11b-deficient macrophages showed an exacerbated secretion of IL-1β. Treating wild-type macrophages with a CD11b agonist, LA1, inhibited MSU-induced release of IL-1β in vitro and attenuated the severity of experimental gouty arthritis. Importantly, LA1, was also effective in human cells as it inhibited MSU-induced release of IL-1β by peripheral blood mononuclear cells from healthy donors. Our data identified the CD11b integrin as a principal cell membrane receptor that modulates NLRP3 inflammasome activation by MSU crystal in macrophages, which could be a potential therapeutic target to treat gouty arthritis in human patients.

中文翻译:


整合素 CD11b 抑制巨噬细胞中 MSU 诱导的 NLRP3 炎症小体激活,并保护小鼠免受 MSU 诱导的关节炎症



在痛风中,尿酸钠晶体被巨噬细胞吸收,触发 NLRP3 炎性体的激活和 IL-1β 的成熟。本研究旨在探讨整合素 CD11b 在 MSU 刺激的巨噬细胞炎症小体激活中的作用。 WT 和 CD11b KO 小鼠的 BMDM 在体外用 MSU 晶体刺激。收集细胞上清液,通过酶联免疫吸附测定和蛋白质印迹方法评估炎症细胞因子的表达。通过关节内注射 MSU 晶体来研究整合素 CD11b 在 MSU 诱导的体内痛风性关节炎中的作用。采用Seahorse细胞外通量分析仪实时测量BMDMs的细胞外酸化率和耗氧率。我们证明,CD11b 缺陷小鼠会出现痛风性关节炎加剧,关节中白细胞募集增加,血清中 IL-1β 水平升高。在巨噬细胞中,CD11b 的基因缺失诱导巨噬细胞代谢从氧化磷酸化转变为糖酵解,从而减少细胞内 ATP 的总体生成。在 MSU 刺激后,CD11b 缺陷型巨噬细胞表现出 IL-1β 分泌加剧。用 CD11b 激动剂 LA1 处理野生型巨噬细胞,可在体外抑制 MSU 诱导的 IL-1β 释放,并减轻实验性痛风性关节炎的严重程度。重要的是,LA1 对人类细胞也有效,因为它可以抑制 MSU 诱导的健康供体外周血单核细胞释放 IL-1β。我们的数据确定 CD11b 整合素是一种主要的细胞膜受体,可通过巨噬细胞中的 MSU 晶体调节 NLRP3 炎症小体的激活,这可能是治疗人类痛风性关节炎的潜在治疗靶点。
更新日期:2024-06-11
down
wechat
bug